Target intelligence / Profile preview

Toll-like receptor 3 and Toll-like receptor 4 (TLR3, TLR4)

Target
TLR3, TLR4
Molecular classification
Receptor, Pattern recognition receptor (PRR), Transmembrane receptor
01

Overview

Toll-like receptors, especially TLR3 and TLR4, are transmembrane pattern recognition receptors that detect pathogenic molecules and initiate powerful innate immune responses, including the production of interferon beta (IFN-β)[2][4]. TLR3 recognizes double-stranded RNA, mainly of viral origin, and signals exclusively through the TRIF adaptor, leading to IRF3/7 activation and robust IFN-β production[2]. TLR4 recognizes bacterial lipopolysaccharide (LPS) and signals through both MyD88-dependent and TRIF-dependent pathways; the latter is critical for IFN-β induction[1][4]. Modulation of TLR signaling has implications for infectious diseases, cancer, and autoimmune conditions, making TLR3 and TLR4 important therapeutic targets. If structure is required, select Toll-like receptor 3 (TLR3) or Toll-like receptor 4 (TLR4) as the canonical targets mediating IFN-β production[2][4]. The phrase "Toll-like receptors mediating IFN-β production" is not a proper canonical name, but a functional description; the correct structured approach would be to specify the individual TLRs involved in the pathway.

Other names
Toll-like receptor 3 (TLR3)Toll-like receptor 4 (TLR4)TLR family (collective reference)Pattern recognition receptor (functional family)
02

Mechanism of action

Agonism: Activates receptor to induce IFN-β and other type I interferons for antiviral/immune modulation. Antagonism: Inhibits receptor to suppress excessive immune/inflammatory response (potentially reduce cytokine storm).

03

Biological functions

Immune responseSignal transductionCytokine inductionAntiviral defenseInflammatory response
04

Disease associations

Infection (viral, bacterial)InflammationCancer (dysregulated TLR signaling implicated in some cases)Autoimmune disease (dysregulated signaling can contribute to pathology)
05

Safety considerations

Excessive activation: risk of cytokine storm or systemic inflammationAutoimmunity: Over-stimulation can contribute to autoimmune or inflammatory diseaseImmunosuppression: Antagonism may dampen host defense
06

Interacting drugs

Imiquimod (TLR7 agonist, similar class)

5 more in the full profile.

07

Biomarkers

IFN-β levels (for efficacy in antiviral responses/immune modulation)Cytokine profiles (IL-6, IL-8, TNF-α)TLR3 and TLR4 expression on immune cells

Beyond the preview

Go deeper on Toll-like receptor 3 and Toll-like receptor 4 (TLR3, TLR4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toll-like receptor 3 and Toll-like receptor 4 (TLR3, TLR4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call